Arden R Barry1, Jonathan D Windram2, Michelle M Graham3. 1. BSc, BSc(Pharm), PharmD, ACPR, was, at the time of writing, with the Mazankowski Alberta Heart Institute, Alberta Health Services, and the Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta. He is now with the Chilliwack General Hospital, Lower Mainland Pharmacy Services, Chilliwack, British Columbia, and the Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia. 2. BSc(Hons), MBChB, MRCP (UK), is with the Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta. 3. MD, FRCPC, is with the Division of Cardiology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta.
Authors: Kathlyn J Ronaldson; Paul B Fitzgerald; Andrew J Taylor; Duncan J Topliss; John J McNeil Journal: Schizophr Res Date: 2011-02-12 Impact factor: 4.939
Authors: Kathlyn J Ronaldson; Paul B Fitzgerald; Andrew J Taylor; Duncan J Topliss; John J McNeil Journal: Aust N Z J Psychiatry Date: 2011-04-27 Impact factor: 5.744
Authors: Steven J Haas; Richard Hill; Henry Krum; Danny Liew; Andrew Tonkin; Lisa Demos; Karen Stephan; John McNeil Journal: Drug Saf Date: 2007 Impact factor: 5.606
Authors: C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt Journal: Clin Pharmacol Ther Date: 1981-08 Impact factor: 6.875
Authors: U E Lang; M Willbring; R von Golitschek; A Schmeisser; K Matschke; S Malte Tugtekin Journal: J Psychopharmacol Date: 2008-02-28 Impact factor: 4.153